References
- Two AM, Wu W, Gallo RL, et al. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72:749–758.
- Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol. 2017;26:659–667.
- Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50:907–912.
- Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci. 2009;55:77–81.
- Two AM, Wu W, Gallo RL, et al. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015;72:761–770. quiz 771–762.
- Del Rosso JQ, Thiboutot D, Gallo R, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. Cutis. 2014;93:134–138.
- Knight AG, Vickers CF. A follow-up of tetracycline-treated rosacea. With special reference to rosacea keratitis. Br J Dermatol. 1975;93:577–580.
- Li Y. Qinghaosu (artemisinin): chemistry and pharmacology. Acta Pharmacol Sin. 2012;33:1141–1146.
- Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17:1217–1220.
- Li T, Zeng Q, Chen X, et al. Effects of artesunate on rosacea-like inflammation in mouse models. Chin J Dermatol. 2017;50:650–653.
- Ho WE, Peh HY, Chan TK, et al. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther. 2014;142:126–139.
- Li T, Hu Y, Yu A, et al. Clinical research of the efficacy of artesunate in 31 patients with rosacea. Chin J Dermatovenereol. 2015;29:330–332.
- Wang G, Gao X, Li T, et al. In vitro activity of artemether against Demodex folliculorum. Chinese Journal of Dermatology. 2016;49:809–811.
- Talghini S, Fouladi DF, Babaeinejad S, et al. Demodex mite, rosacea and skin melanoma; coincidence or association?. Turkiye Parazitol Derg. 2015;39:41–46.
- Schaller M, Almeida LM, Bewley A, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176:465–471.
- Weinkle AP, Doktor V, Emer J. Update on the management of rosacea. Clin Cosmet Investig Dermatol. 2015;8:159–177.
- van Agtmael MA, Eggelte TA, van Boxtel CJ. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci. 1999;20:199–205.
- Chen J, Miao J, Liu M, et al. Different fates of avermectin and artemisinin in China. Sci China Life Sci. 2016;59:634–636.
- Seif el-Din SH, Al-Hroob AM, Ebeid FA. Schistosoma mansoni: N-acetylcysteine downregulates oxidative stress and enhances the antischistosomal activity of artemether in mice. Exp Parasitol. 2011;128:230–235.
- Xiao SH, You JQ, Mei JY, et al. Effect of artemether on glucose uptake and glycogen content in Schistosoma japonicum. Zhongguo Yao Li Xue Bao. 1997;18:363–367.
- Cuzzocrea S, Saadat F, Di Paola R, et al. Artemether: a new therapeutic strategy in experimental rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2005;27:615–630.
- Bunnag D, Viravan C, Looareesuwan S, et al. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. Southeast Asian J Trop Med Public Health. 1991;22:380–385.